Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Biovet JSC's Enterprise Value is лв0.00 Mil.
Biovet JSC's EBIT for the trailing twelve months (TTM) ended in Dec. 2016 was лв19.74 Mil. Therefore, Biovet JSC's EV-to-EBIT ratio for today is 0.00.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Biovet JSC's Enterprise Value is лв0.00 Mil.
Biovet JSC's EBITDA for the trailing twelve months (TTM) ended in Dec. 2016 was лв19.74 Mil. Therefore, Biovet JSC's EV-to-EBITDA ratio for today is 0.00.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Biovet JSC's Enterprise Value is лв0.00 Mil.
Biovet JSC's Revenue for the trailing twelve months (TTM) ended in Dec. 2016 was лв227.36 Mil. Therefore, Biovet JSC's EV-to-Revenue ratio for today is 0.00.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Biovet JSC's Enterprise Value is лв0.00 Mil.
Biovet JSC's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2016 was лв2.85 Mil. Therefore, Biovet JSC's EV-to-FCF ratio for today is 0.00.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Biovet JSC (LTS:0III) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Biovet JSC's current Enterprise Value is лв0.00 Mil.
Biovet JSC's EBIT for the trailing twelve months (TTM) ended in Dec. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was лв19.74 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Biovet JSC's current Enterprise Value is лв0.00 Mil.
Biovet JSC's EBITDA for the trailing twelve months (TTM) ended in Dec. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was лв19.74 Mil.
Biovet JSC's current Enterprise Value is лв0.00 Mil.
Biovet JSC's Revenue for the trailing twelve months (TTM) ended in Dec. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was лв227.36 Mil.
Biovet JSC's current Enterprise Value is лв0.00 Mil.
Biovet JSC's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was лв46.28 Mil.
Biovet JSC's current Enterprise Value is лв0.00 Mil.
Biovet JSC's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was лв2.85 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biovet JSC Enterprise Value Related Terms
Biovet JSC Enterprise Value Historical Data
* Premium members only.
The historical data trend for Biovet JSC's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0III vs ADMP, AGRX, BUDZ: Enterprise Value Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Biovet JSC's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biovet JSC Enterprise Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Biovet JSC's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Biovet JSC's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Biovet JSC's Enterprise Value for the fiscal year that ended in Dec. 2016 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biovet JSC (LTS:0III) has a Enterprise Value of лв0.00 Mil as of Jul. 01, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Biovet JSC and its competitors.
Is Biovet JSC's Enterprise Value too high?
Biovet JSC's current Enterprise Value is лв0.00 Mil.
How does Biovet JSC's Enterprise Value compare to ADMP and AGRX?
Biovet JSC's Enterprise Value of лв0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Drug Manufacturers company?
A good Enterprise Value depends on the Drug Manufacturers industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Biovet JSC and its competitors. Biovet JSC's current Enterprise Value is лв0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biovet JSC stock overvalued right now?
Biovet JSC (LTS:0III) has a current Enterprise Value of лв0.00 Mil. The current Enterprise Value is лв0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Biovet JSC (LTS:0III), the current Enterprise Value is лв0.00 Mil as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Biovet JSC manufactures & markets medicated and nutritional feed additives, enzymes, bulk active substances & pharmaceuticals for animal productivity & health. It offers intermediates, active ingredients and medicines for human pharmaceutical industry.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0III has been successfully added to your 